Posted on: April 28th, 2023
In this week’s blog we say goodbye to Orchard’s Head of Fundraising & Communications, Juliet. Juliet has been volunteering for Orchard since 2020 and started working for Orchard last January. Juliet is moving to Chicago in May and will be sorely missed!
What are you most proud of achieving during your time here?
Last year we were awarded £10,000 from the National Lottery Awards for All funding, we then raised an extra £7,264 from our Christmas appeal. This was for a 3-part video series on OCD, future research, and our patient registry.
We filmed our first video last month and the remaining two last week! I feel so proud seeing the funding in action and can’t wait for our supporters to see these videos.
Any highlights?
We worked hard last year to produce a new Orchard website, although it was a tough task to accomplish, it was definitely a highlight seeing the final product.
I also have really enjoyed organising webinars in partnership with Made of Millions over the years. You can watch our previous ones here.
What are you going to miss the most?
Luckily, I will be returning as a volunteer for Orchard so shouldn’t miss too much on what Orchard is achieving and can still help them achieve their mission to develop new OCD treatments.
However, I am going to miss my friends in the office, they have been my rock since I started working in the office straight after university! (I worked previously at The AKU Society). I am also going to miss working alongside Nick (Chair & Founder of Orchard), he’s an inspiration and I can’t wait to see what he accomplishes next.
What are your future plans?
In May I am moving across the pond to Chicago. I start a new role at Cures Within Reach as a Program Manager. Cures Within Reach works to fund repurposed drug trials, impacting patients with unmet medical needs. I lived in Chicago last summer and can’t wait to go back and experience the city again.
Any last words?
A huge thank you to Orchard for taking me on, I have learned so much about the OCD community, ongoing and OCD future research, I am excited to see what Orchard achieves next in OCD research.